To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Perioperative gabapentin does not reduce postoperative morphine consumption after THA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
December 2015

Perioperative gabapentin does not reduce postoperative morphine consumption after THA

Vol: 4| Issue: 12| Number:50| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Randomized controlled trial of gabapentin as an adjunct to perioperative analgesia in total hip arthroplasty patients

Can J Anaesth. 2015 May;62(5):476-84

Contributing Authors:
JE Paul M Nantha-Aree N Buckley U Shahzad J Cheng L Thabane A Tidy J DeBeer M Winemaker D Wismer D Punthakee V Avram

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

102 patients undergoing primary total hip arthroplasty (THA) were randomized to receive either gabapentin or a placebo preoperatively and for two days postoperatively. The purpose of this study was to determine if gabapentin was effective in reducing postoperative morphine consumption and morphine-associated adverse events. Results demonstrated no significant differences between groups in total mo...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue